
HongShan
A global venture capital and private equity firm investing in technology, healthcare, and consumer sectors.
About
HongShan, formerly Sequoia Capital China, is a leading global venture capital and private equity firm. It invests across seed, venture, growth, buyout, and infrastructure stages, as well as public equities. The firm focuses on identifying transformative technologies and disruptive business models with high growth potential across technology, healthcare, and consumer sectors.
How HongShan invests
Updated Nov 19, 2026, from 8 sources
HongShan is a global venture capital and private equity firm investing from seed through growth in technology, healthcare, and consumer sectors, with its tracked portfolio concentrated in China and Singapore.Portfolio record
What they believe
- Its posts argue that startups should build engaged communities before scaling, as products can be copied but communities cannot, and that early community creates growth advantages that paid acquisition alone cannot match.
hsgcap.com
- Its posts argue that startups should validate assumptions with real users before investing heavily in product development, keeping early releases to the smallest honest experiment that tests whether demand actually exists.
hsgcap.com
The typical investment
Its 15 tracked rounds since 2015 run from Seed through Series B with the most activity in Chinese and Singaporean companies in Ecommerce Retail and AI Agents; it led Excalipoint Therapeutics' $41M Seed in biotech longevity.Portfolio recordbusinesswire.com
Recent moves
May 2026
It closed a $3B Continuation Fund.Source
Aug 2026
It closed a $1.2B Early-Stage Fund.Source
Sep 2026
It joined Manus AI's $500M funding round for AI agents in Singapore.
bloomberg.com
Nov 2026
It joined Variational's $110M Series B for on-chain access to global markets.
businesswire.com
Where the money is heading: Its two most recent tracked investments in Manus AI and Variational sit in AI Agents and Blockchain Web3, against a portfolio that has historically been concentrated in Ecommerce Retail.bloomberg.com
businesswire.comPortfolio record
Measured, not editorial
Ahrefs DR
Below median
Check yoursSecurity
Click to scan
Get notified when HongShan changes
Raised from HongShan, or pitched them? Review them for other founders
Founders pick investors on what other founders say. Your first review on StartupHub.ai also adds $5 in credits (1,250) to your account.
Frequently asked
Is HongShan actively investing?
Yes. HongShan joined 2 rounds in the last 90 days. The most recent was Variational's Series B in November 2026.
What companies has HongShan invested in?
HongShan has invested in Variational, Manus AI, Excalipoint Therapeutics, Rivr, Pinduoduo.
What stage does HongShan invest in?
HongShan invests at Seed, Early Stage, Growth, Buyout, Infrastructure and Pre-Seed.
What sectors does HongShan invest in?
HongShan focuses on Technology, Healthcare, Consumer, AI, Enterprise SaaS and Fintech.
Does HongShan lead rounds?
Yes. HongShan led 3 of the 15 rounds we track.
Who are the partners at HongShan?
The HongShan team we track includes Steve Jia (Partner), Neil Shen (Founding and Managing Partner), Taro Niggemann (Managing Director for Europe) and Colin Guo (Partner), 6 people in all.
SEC filings, insider activity, nonprofit links and pay benchmarks for HongShan:
Max Agent
Get HongShan found by the founders raising now
Founders research investors here and in AI answers before they pitch. StartupHub.ai has 100,000+ visitors a month and new startups every day. Max Agent keeps HongShan ranking where they look.
What it does for HongShan
$79 a month, or $9.99 with our badge on your site
- Checked every week: do ChatGPT, Claude, Perplexity and Gemini name HongShan for searches like "Technology investors"
- Profile, portfolio and team kept current from your site, the news and filings
- A post for your blog every week, on your thesis and portfolio, ready to publish
- Every change sent to Bing, and Google checked daily
- A Monday report of what it did and what moved

